CMT vs NPCE
CMT: Core Molding Technologies is a specialized manufacturer of structural plastic components that serves industrial, transportation, and infrastructure markets through advanced compression and injection molding processes. NPCE: NeuroPace is a medical device company providing the first brain-responsive neuromodulation system that treats drug-resistant epilepsy by delivering personalized, real-time therapy at the seizure source.
Side-by-side fundamentals
| Metric | CMT | NPCE | Edge |
|---|---|---|---|
| Price as of 2026-10-30 close | $22.40 | $12.30 | |
| Market cap | $198M | $422M | |
| P/E as of 2026-10-30 | 26.67 | n/a | |
| Net margin FY2025, SEC XBRL | +4.1% | -21.5% | CMT higher |
| Gross margin FY2025, SEC XBRL | +17.4% | +77.2% | NPCE higher |
| Operating margin FY2025, SEC XBRL | +5.2% | -16.3% | CMT higher |
| ROE FY2025, SEC XBRL | +7.1% | -112.8% | CMT higher |
| ROA FY2025, SEC XBRL | +4.9% | -20.3% | CMT higher |
| Debt / equity filed borrowings, leases excl., balance sheet 2026-06-30 | 0.00 | 4.97 | CMT lower |
| Revenue growth (YoY) FY2025, SEC XBRL | -9.4% | +25.1% | NPCE higher |
| Revenue CAGR (3y) SEC XBRL | -10.1% | +30.0% | NPCE higher |
| Dividend streak (yrs) SEC XBRL | 0 | 0 | Tie |
| Beta as of 2026-09-03 | 0.58 | 1.16 | |
| 1-year return as of 2026-10-30 close | +25.9% | +24.7% | CMT higher |
Fundamentals: SEC XBRL company filings for the figures marked with a fiscal year, and market data, as of 2026-09-03 for the rest. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-10-30.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.